Application of Cortexin to enhance human statokinetic resistance
L. A. Glaznikov, L. G. Buinov, G. A. Ryzhak, V. Kh. Khavinson · 2002 · Medical Academic Journal. 2002;2(3):91–98.
Published 2002-08-29.
Related evidence maps: Military & occupational ↗
Reported findings and study design
Narrative findings; numerical extraction incomplete
Human statokinetic-resistance comparison; nasal Cortexin plus active sensory/vestibular training. Group counts and allocation safeguards unavailable.
Dose, route and schedule
Ten-day intranasal Cortexin course combined with active vestibular, visual, proprioceptive and tactile training. Dose and frequency unavailable in the checked publisher abstract.
Protocol source ↗ · Original publisher abstract, not a fully extracted treatment protocol
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Statokinetic resistance | Improvement compared with control indexes described; no numerical change or uncertainty supplied | |
| Reported treatment program | Ten-day intranasal Cortexin course with active sensory/vestibular training | Dose and frequency unavailable in the checked abstract |
| Attribution and safety gaps | Training contribution, drug-specific effect, adverse-event counts and human nasal pharmacokinetics not established |
A combined training program, not an isolated Cortexin effect. It does not validate PPK-V, exercise-endurance claims or direct nose-to-brain delivery.
Source for the extracted data ↗ · Checked 2026-11-08
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Participant counts, allocation, blinding, dose, exact numerical changes, uncertainty and adverse events absent from the checked abstract.
- Concurrent training prevents attribution to Cortexin alone.
- This is not a PPK-V trial, an exercise-endurance trial or a pharmacokinetic demonstration of nose-to-brain transport.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original publisher abstract; previously linked third-party PDF not fully appraised
Review depth: Publisher abstract checked; full participant flow and outcome tables not extracted
Source access and review scope
Promoted from a bibliography lead to an abstract-level source review. Original publisher metadata checked; training and drug effects cannot be separated from this abstract.
Recorded source-check date: 2026-11-08. This date does not imply a completed systematic review.
Source type: Original human journal publication
Citation and original source
Original source: L. A. Glaznikov, L. G. Buinov, G. A. Ryzhak, V. Kh. Khavinson. Application of Cortexin to enhance human statokinetic resistance Medical Academic Journal. 2002;2(3):91–98. 2002.
Molekul research summary: https://molekul.io/research/cortexin-motion-2002. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry